Trademark Overview
On Tuesday, July 1, 2025, a trademark application was filed for NCDX with the United States Patent and Trademark Office. The USPTO has given the NCDX trademark a serial number of 99261816. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 1, 2025. This trademark is owned by Flavocure Biotech, Inc.. The NCDX trademark is filed in the Pharmaceutical Products category with the following description:
Diagnostic agent for medical purposes; diagnostic agent for medical use, namely, diagnostic agent for in vivo use; pharmaceutical diagnostic preparations for medical use; pharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases; composition for detection and diagnosis of central nervous system disorders, cancers, and inflammatory diseases.